contact@welcomeurope.com

HORIZON EUROPE – Cluster 1 – Health (Single stage – 2027/1) – 2027

Pillar 2 of the Horizon Europe programme aims to boost innovation, competitiveness, and employment in Europe through collaborative projects, international partnerships, and funding opportunities accessible to companies of all sizes and sectors.

2027-04-13
341.6 million euros
Open

Call synthesis

Call reference HORIZON-HLTH-2027-01
Programme HORIZON EUROPE
Institution European Commission
Sectors Health Research & Innovation
Beneficiaries Large company (> 250 employees) Research centre & university Smes & Start-Ups (< 249 Employees)

Content reserved for subscribers

Call reference

HORIZON-HLTH-2027-01



Register for free to access the content

Free access to all information

Priorities and funded actions

Some Horizon Europe budgets are structured in response to policy ambitions (“destinations”) and deployed through calls for proposals targeting more specific thematic/sector (“Topics”). Thus, your application must be linked to a topic of a call for proposals.

 

Various categories of projects are eligible:

  • RIA, Research and Innovation Actions: Basic and applied research / Technology development and adoption / Testing and validation of a prototype in the laboratory ;
  • IA, Innovation Actions: Prototypes, tests, demonstrations, pilot projects, market placement. These actions may include limited R&D activities ;
  • CSA, Coordination and Support Actions: Networking, studies & conferences, communication, studies for new research infrastructures ;
  • MSCA, Marie Skłodowska-Curie Actions / ERC individual grants: Training networks for researchers, Individual grants for experienced researchers, Staff exchange – mobility for researchers and non-scientific staff.

In addition, calls specify the categories of eligible beneficiaries:

  • Collaborative projects, composed of a coordinator and several partners organisations (consortium) ;
  • Single-beneficiary projects, involving a single organization ;
  • Individual scholarships, open to natural persons in their own name with their home institution.

TOPICS:

Forthcoming

  • HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
  • HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
  • HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
  • HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
  • HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
  • HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
  • HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
  • HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
  • HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
  • HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

Additional information

Useful

Financement
  • Total budget of the call: 341.6 million euros
  • Budget per topic:
    • HORIZON-HLTH-2027-01-CARE-02: 38 million euros
    • HORIZON-HLTH-2027-01-DISEASE-05: 44.2 million euros
    • HORIZON-HLTH-2027-01-DISEASE-06: 37.3 million euros
    • HORIZON-HLTH-2027-01-DISEASE-07: 37.3 million euros
    • HORIZON-HLTH-2027-01-DISEASE-08: 44.2 million euros
    • HORIZON-HLTH-2027-01-DISEASE-10: 11.8 million euros
    • HORIZON-HLTH-2027-01-ENVHLTH-02: 45 million euros
    • HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: 20 million euros
    • HORIZON-HLTH-2027-01-IND-01: 24.5 million euros
    • HORIZON-HLTH-2027-01-STAYHLTH-01: 39.3 million euros
  • Amount of the grant: between 3 million and 11 million euros
  • Funding rate: up to 100% of the total eligible costs